Compagnie Lombard Odier S Cm A Astrazeneca PLC Transaction History

Compagnie Lombard Odier S Cm A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$61.89 - $69.28 $24,756 - $27,712	400 New	400 $26,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $29,630 - $35,570	-500 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$55.56 - $60.79 $16,668 - $18,237	-300 Reduced 37.5%	500 $30,000
Q1 2021 Apr 23, 2021	BUY	$47.16 - $54.44 $37,728 - $43,552	800 New	800 $40,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $5,160 - $5,808	-140 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $5,703 - $6,336	-173 Reduced 55.27%	140 $5,000
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $5,551 - $6,016	173 Added 123.57%	313 $11,000
Q2 2017 Aug 14, 2017	BUY	N/A	140	140 $5,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.